News

Study: Lilly drug keeps common lung cancer under control in elderly patients

BY Alaric DeArment

INDIANAPOLIS — A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

Lilly released results of the 939-patient phase-3 "PARAMOUNT" study, which found that maintenance therapy with the injected drug Alimta (pemetrexed), added to the chemotherapy drug cisplatin, reduced the risk of disease progression in patients ages 70 years and older with advanced nonsquamous no-small cell lung cancer, or NSCLC.

In the study, patients were given Alimta or a placebo. Among the 92 patients ages 70 years and older, Alimta reduced the risk of disease progression by 65% compared with placebo. Among those younger than 70 years, the drug reduced disease progression by 31%.

Results from the analysis were presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

GMDC releases top 10 scanned displays from its convention “Showcase”

BY DSN STAFF

COLORADO SPRINGS, Colo. — Global Market Development Center last week named the top 10 scanned items from the 41st annual Global Market Development Center Health Beauty Wellness Marketing Conference.

Those products that generated the most interest among retail buyers were featured in GMDC’s "Showcase," which allows suppliers to display featured products or new items in a wide variety of merchandising formats, including counter displays, wing panels and floor displays, for example. In addition, GMDC featured a "Showcase Plus" option that allowed companies to highlight a complete line of products within a 4-ft. section.

“The GMDC Showcase was invaluable and always exceeds our expectations," stated Brian Duff, GMDC board member and SVP procurement and marketing for Associated Food Stores. "Pre-scheduled appointments made it easy to see many different product lines featured all in one place without having to search through the typical booth show environment. It was easy for us to pick up products, smell fragrances, see how the product is merchandised and identify new innovations, while receptions in the Showcase allowed us to talk with the supplier in a very relaxed atmosphere."

The top 10 scanned items were:

  1. Purell Seasonal Displays from GOJO Industries

  2. Portable Durable Floor Display from Cashco Distributors

  3. HBW Trial Size Department from TWT Distributing

  4. Travel Guard Floor Display from Sprayco

  5. 4-in. VisiBin from Cashco Distributors

  6. Disney Cotton Swabs Vanity Pak from Cotton Buds

  7. Act Kids Floorstand from Chattem

  8. Gold Bond Ultimate Ribbons from Chattem

  9. Help 36-count Display from Help Remedies

  10. Hello Kitty/Spiderman Pedo Kit from Dr. Fresh

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Prevalence of asthma among children with diabetes noted in study

BY Allison Cerra

NEW YORK — There seems to be a significant presence of asthma among children with diabetes, and those with both chronic illnesses have a difficult time controlling their blood-sugar levels, according to new research.

The study, published in the Sept. 26 edition of Pediatrics, involved a cross-sectional analysis of data from the SEARCH for Diabetes in Youth study betweem 2002 and 2005, which included 1,683 children diagnosed with Type 1 diabetes (known as juvenile diabetes), as well as 311 children diagnosed with Type 2 diabetes. The subjects’ asthma status and medications were gathered from medical records and self-administered questionnaires, while glycemic control was assessed from hbA1C measured at the study visit, the company said. The study authors found that the prevalence of asthma among Type 1 diabetes patients was 10%, while prevalence among Type 2 diabetes patients was 16.1%. Additionally, the prevalence also varied by ethnicity, the study authors noted.

What’s more, those asthma were more likely to have poor glycemic control, especially those with Type 1 diabetes whose asthma was not treated with pharmacotherapy.

The study authors said that while this association isn’t clear, they concluded that specific asthma medications may decrease systemic inflammation, which may cause the complex relationship between pulmonary function, body mass index and glycemic control among youth with diabetes.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES